PCI Pharma Services
Philadelphia, PA 19114
PCI is a full service provider to global healthcare companies offering unparalleled expertise and experience in taking compounds from the earliest stages of development through to successful commercialization, delivering speed-to-market and commercial success for our customers.
Formulation Development, Clinical Trial Supply, Commercial Manufacturing & Packaging, Storage & Distribution
PCI Pharma Services is an integrated full service provider, a proven and trusted partner to leading companies in the global healthcare industry. We offer unparalleled expertise and experience in taking compounds from the earliest stages of development through to successful commercialization, delivering speed-to-market and commercial success for our customers.
State-of-the-art cGMP facilities in North America and Europe support products destined to over 100 countries; site segregation for Sch II-V Controlled Substances, Animal Health, Hormonal Products, Penicillin Products, Cytotoxins, SafeBridgeTM Band 1-4 Potent Compounds; Cold Chain packaging and distribution at 2-8°C, -20°C, -40°C, -80°C, and -196°C for Advanced Therapeutic Medicinal Products (ATMPs); low humidity packaging; and modified environments for oxygen and light sensitive products.
Full service Formulation Development including Analytical Development/Characterization.
CLINICAL TRIAL SERVICES:
Tablet, Capsule, Powder and Liquids Manufacturing, Analytical Development, Stability Testing, Clinical Packaging & Labeling including product Blinding & Randomization, Global Storage & Distribution, as well as Returns Management & Destruction.
Commercial drug manufacturing including Commercial scale-up. Packaging Services for Oral Solids, Powders, Liquids, Creams, and Gels, as well as Injectable & Parenteral Delivery forms including Device Assembly. Analytical & Stability Services in support of commercial supply.
Contained manufacturing and packaging services for clinical and commercial medicines. PCI’s state- of-the-art, purpose-built, contained manufacturing site handles potent compounds with OEL’s down to 0.01μg/m3, and was recognized by ISPE as a Facility of the Year in 2013. Contained potent compound manufacturing is further supported by segregated, purpose-built packaging facilities in both Europe and North America.
Leveraging over 5 years of commercial Serialization services to domestic and emerging markets, PCI offers clients both integrated and stand-alone Serialization solutions.
In October 2017, PCI acquired Millmount Healthcare, located in Dublin, Ireland in the European Union.